¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Malignant neoplasm of prostate"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • malignant fibrous histiocytoma
    ¾Ç¼º¼¶À¯Á¶Á÷±¸Á¾
  • malignant hidradenoma
    ¾Ç¼º¶¡»ùÁ¾
  • malignant hypertension
    ¾Ç¼º°íÇ÷¾Ð
  • malignant hyperthermia
    ¾Ç¼º°í¿­
  • malignant melanoma
    ¾Ç¼ºÈæ»öÁ¾
  • malignant mesothelioma
    ¾Ç¼ºÁßÇÇÁ¾
  • malignant myopia
    ¾Ç¼º±Ù½Ã
  • malignant smallpox
    ¾Ç¼º¸¶¸¶
  • malignant teratoma
    ¾Ç¼º±âÇüÁ¾
  • malignant transformation
    ¾Ç¼ºÀüȯ
  • malignant tumor
    ¾Ç¼ºÁ¾¾ç
  • neuroleptic malignant syndrome
    ½Å°æÀÌ¿ÏÁ¦¾Ç¼ºÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • malignant progressive histiocytoma
    ¾Ç¼ºÁøÇàÁ¶Á÷±¸Á¾
  • malignant
    ¾Ç¼º-
  • malignant acanthosis nigricans
    ¾Ç¼ºÈæ»ö°¡½Ã¼¼Æ÷Áõ
  • malignant melanoma
    ¾Ç¼ºÈæ»öÁ¾
  • malignant myopia
    (¢¡degenerative myopia) º¯¼º±Ù½Ã
  • malignant smallpox
    ¾Ç¼º¸¶¸¶
  • malignant teratoma
    ¾Ç¼º±âÇüÁ¾
  • malignant transformation
    ¾Ç¼º¼¼Æ÷Àüȯ
  • malignant tumor
    ¾Ç¼ºÁ¾¾ç
  • malignant chondroid syringoma
    ¾Ç¼º¿¬°ñ¶¡°üÁ¾
  • malignant mast mast reticulosis
    ¾Ç¼ººñ¸¸¼¼Æ÷±×¹°Áõ, ¾Ç¼ººñ¸¸¼¼Æ÷¼¼¸ÁÁõ
  • neuroleptic malignant syndrome
    Ç×Á¤½Åº´¾à¹°¾Ç¼ºÁõÈıº
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • prostate carcinoma
    Àü¸³¼±¾ÏÁ¾(îñí¡àÍäßðþ)
  • prostate gland
    Àü¸³»ù, Àü¸³¼±(îñí¡àÍ).
  • prostate gland
    Àü¸³¼±
  • prostate specific antigen
    Àü¸³¼±Æ¯ÀÌÇ׿ø
  • prostate utricle
    Àü¸³¼±¼Ò½Ç
  • prostate-specific antigen
    Àü¸³¼±Æ¯ÀÌÇ׿ø(îñí¡àÍ÷åì¶ù÷ê«)
  • prostate-specipic antigen
    Àü¸³¼±Æ¯ÀÌÇ׿ø
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • base of prostate
    Àü¸³»ù¹Ù´Ú
  • body of prostate
    Àü¸³»ù¸öÅë
  • capsule of prostate
    Àü¸³»ùÇǸ·
  • carcinoma of prostate
    Àü¸³¼±¾Ï
  • cyst of prostate
    Àü¸³¼±³¶(îñí¡àÍÒ¥).
  • disseminated part of prostate
    Àü¸³»ùÆÛÁüºÎºÐ
  • fascia of prostate
    Àü¸³»ù±Ù¸·
  • isthmus of prostate
    Àü¸³»ùÀß·è
  • levator muscle of prostate<³ª> musculus l. prostatae
    Àü¸³¼±(îñí¡àÍ)°Å±Ù.
  • ligament of prostate
  • prostate
    Àü¸³»ù, Àü¸³¼±(îñí¡àÍ).
  • prostate
    Àü¸³»ù
  • prostate
    Àü¸³¼±
  • prostate
    Àü¸³¼±(îñí¡àÍ)
  • prostate capsule
    Àü¸³¼±ÇǸ·
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CEA Carcino-Embryonic Antigen [HP 1825-6]
  ; Oncofetal Antigens
  ; Glycopro...
CBN cannabinol; central benign neoplasm; Commission on Biological Nomenclature
GENPS genital neoplasm-papilloma syndrome
NEA neoplasm embryonic antigen; no evidence of abnormality
Neo neomycin; neoplasm or neoplastic
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MEO Malignant External Otitis
MFH malignant fibrous histocytoma
MH Malignant Histiocytosis
MH Malignant Hyperpyrexia
MH Malignant Hyperthermia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • malignant granuloma
    ¾Ç¼º À°¾ÆÁ¾
    ¾Ç¼º ¸²ÇÁÁ¾, º£°Ô³Ê À°¾ÆÁ¾°ú ´Ù¸£Áö¸¸ ±× º´ ÀÚü°¡ ¹àÇôÁöÁö ¾Ê¾Æ Á¾¾ç ¿©ºÎ Á¶Â÷µµ È®½ÇÇÏÁö ¾ÊÀºµ¥, ±«»ç¼º º´º¯ÀÌ ³Ê¹« °­ÇϹǷΠº´¸®Á¶Á÷ÇÐÀû °Ë»öµµ °ï¶õÇÏ´Ù. Àü½Å¼º ÀüÀÌ´Â ÀûÀ¸³ª ±¹¼ÒÀû ±«»ç ÁøÇàÀÌ ´ë´ÜÈ÷ ºü¸£°í ¼¼±Õ °¨¿°À» ÀÏÀ¸Å°±â ½¬¿ì¸ç ÆÐÇ÷Áõ°ú À¯»çÇÑ °£Çæ ¿­°ú °í¿­ÀÌ ÀϾ Àü½ÅÀÌ ¼è¾àÇØÁö°í ¿¹Èİ¡ ³ª»Ú´Ù.
  • malignant hemocytoblastoma
    ¾Ç¼º Ç÷±¸¸ð¼¼Æ÷Á¾
  • malignant hyperthermia
    ¾Ç¼º °í¿­Áõ, ¾Ç¼º °í¿­
    ¸¶Ãë Áß¿¡ °©ÀÚ±â °í¿­À» ³»°í »ç¸Á·üÀÌ ±ØÈ÷ ³ôÀº ÁõÈıº¿¡ ´ëÇÏ¿© À̸§ÀÌ ºÙ¿©Áø °ÍÀÌ´Ù. Áõ»óÀº È£ÈíÀ̳ª ¸Æ¹ÚÀÌ »¡¶óÁö°í ü¿ÂÀº 5ºÐ¿¡ 1¡É Á¤µµÀÇ ¼Óµµ·Î 42¡É¿¡³ª ´ÞÇÑ´Ù. µ¿½Ã¿¡ ±ÙÀÇ °æÁ÷À̳ª °ú±äÀåÀÌ »ý±â°í ´ë»ç¼º ¹× È£Èí¼º »êÁõ, °íÄ®·ýÇ÷ÁõÀÌ ³ªÅ¸³­´Ù. ±Ù°æÁ÷¼º À§Ãà, À¯ÀüÀÚ ÀÎÀÚ
  • malignant hyperthermia syndrome
    ¾Ç¼º °í¿­ ÁõÈıº
  • malignant lesion
    ¾Ç¼º º´¼Ò
  • malignant melanoma
    ¾Ç¼º Èæ»öÁ¾
    1. ¿ÜÀ½¿¡ »ý±â´Â °¡Àå Áß¿äÇÑ º´º¯ÀÎ Á¾¾çÀÇ ÀÏÁ¾À¸·Î ¿ÜÀ½ÀÇ ¾Ç¼º Èæ»öÁ¾Àº µå¹°°í, ¿©¼º¿¡¼­ °üÂûµÇ´Â Èæ»öÁ¾ÀÇ 2%°¡ ¿ÜÀ½¿¡¼­ ¹ß»ýÇÑ´Ù. 2. »ö¼Ò ¼¼Æ÷¿¡ »ý±ä ¾Ç¼º Á¾¾ç. 3. Ç¥ÇǼº Èæ»ö±¸¿Í ±× Àü±¸Ã¼·ÎºÎÅÍ ¹ß»ýÇÏ´Â ´ë´ÜÈ÷ ¾Ç¼ºÀÎ Á¾¾çÀÌ´Ù. ¸ðµç ¾Ç¼º Á¾¾ç Áß 1%°¡ ¾Ç¼º Èæ»öÁ¾ÀÌ´Ù. ÀÌÁß 90%´Â ¿ÜÇÇ¿¡ ³ªÅ¸³ª°í 10%´Â ÇǺΠ¿Ü¿¡ ³ªÅ¸³­´Ù. ¸ðµç ¾Ç¼º Èæ»öÁ¾ Áß 1%´Â ±¸°­ ³»¿¡¼­ ¹ß»ýÇÑ´Ù. ¹ß»ýÀ²ÀÌ Áõ°¡µÇ´Â °Íó·³ º¸ÀÌ´Â ÀÌ·± Á¾¾çÀÇ Æ¯È÷ ³ª»Û Á¡Àº ¸²ÇÁ ¼øÈ¯°ú Ç÷¾× ¼øÈ¯À» ÅëÇØ ºü¸£°Ô ÀüÀ̵Ǵ °ÍÀÌ´Ù.
  • malignant mesenchymoma
    ¾Ç¼º ³»¹è¿±Á¾
  • malignant myopia
    ¾Ç¼º ±Ù½Ã
    Ã༺ ±Ù½Ã·Î¼­ ¾ÈÃàÀåÀÌ ±¼Àý·Â¿¡ ºñÇØ ³Ê¹« ±æ¾î ÆòÇà ±¤¼±ÀÌ ¸Á¸· ¾Õ¿¡ ÃÊÁ¡À» ¸ÎÀ¸¹Ç·Î ¼±¸íÇÏÁö ¾ÊÀº »óÀ» ¸Î°Ô µÈ´Ù. °úµµÇÑ Á¶Àý ¹× ´« ¸ðÀ½, ½Ã½Å°æ À¯µÎÀÇ ºÎÁ¾, ³»ºÐºñ ÀÌ»ó, Æí½Ä µîÀÌ ¿øÀÎÀ̶ó°í ÇÏ´Â ÁÖÀåµµ ÀÖÀ¸³ª ºÐ¸íÄ¡ ¾Ê´Ù.
  • malignant oxyphilic adenoma
    ¾Ç¼º È£»ê¼º ¼±Á¾
  • malignant plasma cell
    ¾Ç¼º ÇüÁú ¼¼Æ÷
  • malignant pleomorphic adenoma
    ¾Ç¼º ´ÙÇü¼º ¼±Á¾
  • malignant salivary gland tumor
    ¾Ç¼º Ÿ¾×¼± Á¾¾ç
  • malignant tumor
    ¾Ç¼º Á¾¾ç
    Á¤»óÀûÀÎ Á¶Á÷ ¼¼Æ÷°¡ °¢Á¾ ¹°¸®Àû, È­ÇÐÀû, »ý¹°ÇÐÀûÀÎ ¾Ï¿ø¼º ¹°ÁúÀÇ ÀÛ¿ë ¶Ç´Â ¿äÀο¡ ÀÇÇØ µ¹¿¬º¯À̸¦ ÀÏÀ¸ÄѼ­ Çü¼ºµÇ´Â Á¾¾ç ¹«Á¦ÇÑÀÇ ¼¼Æ÷ ºÐ¿­·Î ¸Å¿ì ¿Õ¼ºÇÏ°Ô Áõ½ÄÇÏ¿© ÁÖÀ§ Á¶Á÷À» ÆÄ±«, ħ½ÄÇÑ´Ù. ¶Ç ¾î¶² È­Çй°ÁúÀ» ³»¾î ÁÖÀ§ÀÇ Á¶Á÷ ¼¼Æ÷¸¦ Ä§ÇØÇÒ »Ó¸¸ ¾Æ´Ï¶ó, Ç÷°ü ¹× ¸²ÇÁ°üÀ» µû¶ó ÀüÀÌÇÏ¿© Àü½ÅÀÇ ¾Ç¾×ÁúÀ» ¾ß±â½ÃÄÑ Á×À½ÀÇ À§ÇèÀ» ÃÊ·¡ÇÑ´Ù. »óÇǼºÀÎ °ÍÀ» ¾ÏÁ¾À̶ó Çϰí, ºñ»óÇǼºÀÎ °ÍÀ» À°Á¾À̶ó ÇÑ´Ù.
  • non-malignant
    ºñ¾Ç¼º
  • nonodontogenic malignant tumor jaw
    ºñÄ¡¾Æ¼º ¾Ç¼º Á¾¾ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
neoplasm staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.
(12 Dec 1998)
neoplasm transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes.
(12 Dec 1998)
DNA, neoplasm DNA present in neoplastic tissue.
(12 Dec 1998)
drug resistance, neoplasm Resistance or diminished response of a neoplasm to an antineoplastic agent in humans, animals, or cell or tissue cultures.
(12 Dec 1998)
amyloid bodies of the prostate An obsolete term for small masses of colloid material often present in the tubules of the gland.
See: corpus amylaceum.
(05 Mar 2000)
anterior surface of prostate The anterior surface of the prostate.
Synonym: facies anterior prostatae.
(05 Mar 2000)
apex of prostate The lowermost part of the prostate, situated above the urogenital diaphragm.
Synonym: apex prostatae.
(05 Mar 2000)
base of prostate The broad upper surface of the prostate contiguous with the bladder wall.
Synonym: basis prostatae.
(05 Mar 2000)
cancer, prostate Cancer of the gland that produces some of the components of semen fluid. Prostate cancer is the second leading cause of death of males in the U.S. Prostate cancer is often first detected as a hard nodule during a routine rectal examination. The PSA blood test is a screening test for prostate cancer. Diagnosis of prostate cancer is established when cancer cells are identified in prostate tissue obtained by a biopsy. In some patients, prostate cancer is life threatening. In many others, prostate cancer can exist for years without causing any health problems. Treatment options for prostate cancer include observation, radiation therapy, surgery, hormonal therapy, and chemotherapy.
(12 Dec 1998)
glandular substance of prostate The glandular tissue of the prostate as distinct from the stroma and capsule.
Synonym: substantia glandularis prostatae.
(05 Mar 2000)
middle lobe of prostate The portion of the prostate lying between the urethra and the ejaculatory ducts; indistinct unless hypertrophied.
Synonym: lobus medius prostatae, Morgagni's caruncle.
(05 Mar 2000)
muscular substance of prostate The smooth muscle in the stroma of the prostate.
Synonym: substantia muscularis prostatae, musculus prostaticus.
(05 Mar 2000)
posterior surface of prostate The posterior surface of the prostate.
Synonym: facies posterior prostatae.
(05 Mar 2000)
prostate A small conical gland at the base of the male bladder and surrounding the first part of the urethra.
(27 Sep 1997)
prostate acid phosphatase An enzyme produced by the prostate that is elevated in some patients with prostate cancer.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á